Fig. 2.
Forrest plot comparing the absolute (CD4, CD8, Treg) or percent (all others) change of different T-cell subsets in peripheral blood in patients with HCC before and 28 days after tremelimumab treatment (*p < 0.05; **p < 0.0001)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.